Pharmaceutical Intermediates Market Size, Share, Analysis, 2028

Free Sample PDF Inquiry Before Buying
Pharmaceuticals Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (GMP, and Non GMP); Applications (Antibiotics, Antipyretic Analgesics, Vitamins, and Others); Distribution Channel (Distributor, and Direct Sales), and Geography

Publication Month: May 2021 | Report Code: TIPRE00005559 | No. of Pages: 185 | Category: Pharmaceuticals | Status: Published

The pharmaceutical intermediates market is expected to reach US$ 37,290.33 million in 2028 from US$ 27,356.70 million in 2020. The market is estimated to grow with a CAGR of 4.2% from 2021-2028.

The pharmaceutical intermediates market has been analyzed on the basis of type, application, distribution channel, and region. The market based on region is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report emphasizes on parameters such as market trends, technological advancements, market dynamics, and leading company’s competitive landscape analysis to offers insights and in-depth analysis of the pharmaceutical intermediates market. It also includes the analysis of COVID-19 pandemic across the market in all the key regions.

Lucrative Regions for Pharmaceutical Intermediates Market

Lucrative Regions for Pharmaceutical Intermediates Market

Get more information on this report :


Market Insights

Rising Prevalence of Chronic Diseases and Infectious Diseases

Pharmaceutical intermediates are the building blocks of active pharmaceutical ingredients (APIs). These are raw materials that undergo molecular change or processing during bulk drug production. Thus, the requirement of pharmaceutical intermediates increases with the rise in demand for drugs to treat chronic diseases. As per the Centers for Disease Control and Prevention (CDC), 6 in 10 adults in the US suffer from at least one chronic disease such as cancer, heart disease, lung disease, stroke, neurological disease, diabetes, and kidney diseases. Moreover, 4 in 10 adults in the country have two or more chronic diseases. Additionally, according to the press release by the European Chronic Disease Alliance (ECDA), in 2014, 9 out of 10 people in Europe die due to chronic diseases. Thus, 70–80% of the total healthcare costs are spent on the management of chronic diseases.

The surging prevalence of infectious diseases, especially in Southeast Asia, is also likely to propel the demand for APIs in the coming years, eventually driving the growth of the pharmaceutical intermediate market. For instance, as per the Revised National Tuberculosis Control Programme Report, around 4.4 lakh patients died due to tuberculosis in India in 2018, that is 29% of the total 1.5 million deaths caused by the disease across the world. Thus, such high prevalence of chronic diseases and infectious diseases is bolstering the demand for drugs, eventually highlighting the need of pharmaceutical intermediates.

Type-Based Insights

The pharmaceutical intermediates market, by type, is segmented into GMP, and non GMP. The GMP segment held the largest share of the market in 2020, whereas the same segment is anticipated to register the highest CAGR of 4.4% in the market during the forecast period.


Pharmaceutical Intermediates Market, by Type – 2020 and 2028

Pharmaceutical Intermediates Market, by Type – 2020 and 2028

Get more information on this report :


Application-Based Insights

The pharmaceutical intermediates market, by application, is segmented antibiotics, antipyretic analgesics, vitamins, and others. The antibiotics segment held the largest share of the market in 2020, also, this segment is anticipated to register the highest CAGR of 4.9% in the market during the forecast period.


Distribution Channel-Based Insights

On the basis of distribution channel, the pharmaceutical intermediates market has been segmented into distributor, and direct sales. The direct sales segment held the largest share of the market in 2020, and distributor segment is estimated to register the highest CAGR of 4.2% in the market during the forecast period.

Strategic Insights

Companies operating in the pharmaceutical intermediates market are adopting organic strategies such as product launches and expansions to expand their footprint and product portfolio worldwide as well as to address the growing demands.

By Type

  • GMP
  • Non-GMP

By Application

  • Antibiotics
  • Antipyretic Analgesics
  • Vitamins
  • Others

By Distribution Channel

  • Distributor
  • Direct Sales

By Geography

  • North America

    • US
    • Canada
    • Mexico

  • Europe

    • Germany
    • France
    • Italy
    • United Kingdom
    • Spain
    • Switzerland
    • Belgium
    • Greece
    • Norway
    • Portugal
    • Sweden
    • Czech Republic
    • Croatia
    • Ireland
    • Denmark
    • Netherland
    • Russia
    • Rest of Europe

  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC

  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Rest of MEA

  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Pfizer, Inc
  • Dishman Group
  • Dextra Laboratories Limited
  • Sanofi Winthrop Industries S.A.
  • Vertellus Holdings LLC
  • BASF SE
  • Lianhetech
  • Codexis
  • Midas Pharma GmbH
  • Chiracon GmbH

Frequently Asked Questions

What are the driving factors for the Pharmaceutical Intermediates market across the globe?
Key factors that are driving the market are to rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities. However, high cost of drug manufacturing hinders the market growth.
What are Pharmaceutical Intermediates?
Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs as well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.
What is the cost of Pharmaceutical Intermediates?
The costs of the Pharmaceutical Intermediates are much higher, and they may cost US$ 5–50, or more, per kgs. The cost may also differ from product to product types.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Pharmaceutical Intermediates Market – By Type

1.3.2 Global Pharmaceutical Intermediates Market – By Application

1.3.3 Global Pharmaceutical Intermediates Market – By Distribution Channel

1.3.4 Global Pharmaceutical Intermediates Market– By Geography

2. Pharmaceutical Intermediates Market– Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Pharmaceutical Intermediates Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 APAC PEST Analysis

4.2.4 MEA PEST Analysis

4.2.5 SCAM PEST Analysis

4.3 Expert Opinion

5. Pharmaceutical Intermediates Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Chronic Diseases and Infectious Diseases

5.1.2 Escalating R&D Investments by Pharmaceutical Companies

5.2 Market Restraints

5.2.1 High Cost of Manufacturing

5.3 Market Opportunities

5.3.1 Emerging Markets

5.4 Future Trends

5.4.1 Increasing Adoption of AI-based Tools for Drug Discovery

5.5 Impact Analysis

6. Pharmaceutical Intermediates Market– Global Analysis

6.1 Global Pharmaceutical Intermediates Market Revenue Forecast and Analysis

6.2 Global Pharmaceutical Intermediates Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Pharmaceutical Intermediates Market Analysis – By Type

7.1 Overview

7.2 Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

7.3 GMP

7.3.1 Overview

7.3.2 GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Non GMP

7.4.1 Overview

7.4.2 Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8. Pharmaceutical Intermediates Market Analysis – By Application

8.1 Overview

8.2 Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

8.3 Antibiotics

8.3.1 Overview

8.3.2 Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Antipyretic Analgesics

8.4.1 Overview

8.4.2 Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.5 Vitamins

8.5.1 Overview

8.5.2 Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

8.6 Other

8.6.1 Overview

8.6.2 Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9. Pharmaceutical Intermediates Market– By Distribution Channel

9.1 Overview

9.2 Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

9.3 Distributor

9.3.1 Overview

9.3.2 Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

9.4 Direct Sales

9.4.1 Overview

9.4.2 Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

10. Pharmaceutical Intermediates Market – Geographical Analysis

10.1 North America: Pharmaceutical Intermediates Market Revenue and Forecast to 2028

10.1.1 Overview

10.1.2 North America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.3 North America: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.4 North America: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.5 North America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6 North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.1.7 US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.1 US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.2 US: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.7.3 US: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.7.4 US: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.8 Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.1 Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.2 Canada: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.8.3 Canada: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.8.4 Canada: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.9 Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.9.1 Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.1.9.2 Mexico: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.1.9.3 Mexico: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.1.9.4 Mexico: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.2 Europe: Pharmaceutical Intermediates Market Revenue and Forecast to 2028

10.2.1 Overview

10.2.2 Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.3 Europe: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.2.4 Europe: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.2.5 Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.6 Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.2.7 Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.7.1 Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.7.2 Germany: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.2.7.3 Germany: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.2.7.4 Germany: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.8 UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.8.1 UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.8.2 UK: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.2.8.3 UK: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.2.8.4 UK: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.9 France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.9.1 France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.9.2 France: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.2.9.3 France: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.2.9.4 France: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.10 Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.10.1 Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.10.2 Spain: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.2.10.3 Spain: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.2.10.4 Spain: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.11 Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.11.1 Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.11.2 Italy: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.2.11.3 Italy: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.2.11.4 Italy: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.12 Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.12.1 Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.2.12.2 Rest of Europe: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.2.12.3 Rest of Europe: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.2.12.4 Rest of Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.3 Asia Pacific: Pharmaceutical Intermediates Market Revenue and Forecast to 2028

10.3.1 Overview

10.3.2 Asia Pacific: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.3 Asia Pacific: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.3.4 Asia Pacific: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.3.5 Asia Pacific: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.6 Asia Pacific: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.3.7 China: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.7.1 China: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.7.2 China: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.3.7.3 China: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.3.7.4 China: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.8 Japan: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.8.1 Japan: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.8.2 Japan: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.3.8.3 Japan: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.3.8.4 Japan: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.9 India: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.9.1 India: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.9.2 India: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.3.9.3 India: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.3.9.4 India: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.10 Australia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.10.1 Australia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.10.2 Australia: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.3.10.3 Australia: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.3.10.4 Australia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.11 South Korea: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.11.1 South Korea: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.11.2 South Korea: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.3.11.3 South Korea: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.3.11.4 South Korea: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.12 Rest of Asia Pacific: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.12.1 Rest of Asia Pacific: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.3.12.2 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.3.12.3 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.3.12.4 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.4 Middle East & Africa: Pharmaceutical Intermediates Market Revenue and Forecast to 2028

10.4.1 Overview

10.4.2 Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.3 Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.4.4 Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.4.5 Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.4.6 Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.4.7 Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.7.1 Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.7.2 Saudi Arabia: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.4.7.3 Saudi Arabia: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.4.7.4 Saudi Arabia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.4.8 UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.8.1 UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.8.2 UAE: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.4.8.3 UAE: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.4.8.4 UAE: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.4.9 South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.9.1 South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.9.2 South Africa: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.4.9.3 South Africa: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.4.9.4 South Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.4.10 Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.10.1 Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.4.10.2 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.4.10.3 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.4.10.4 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.5 South and Central America: Pharmaceutical Intermediates Market Revenue and Forecast to 2028

10.5.1 South and Central America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.5.2 South and Central America: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.5.3 South and Central America: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.5.4 South and Central America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.5 South and Central America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

10.5.6 Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1 Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2 Brazil: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.5.6.3 Brazil: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.5.6.4 Brazil: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.7 Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.5.7.1 Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.5.7.2 Argentina: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.5.7.3 Argentina: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.5.7.4 Argentina: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.8 Rest of South and Central America: Pharmaceutical Intermediates Market- Revenue and Forecasts to 2027 (USD Million)

10.5.8.1 Rest of South and Central America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

10.5.8.2 Rest of South and Central America: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)

10.5.8.3 Rest of South and Central America: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)

10.5.8.4 Rest of South and Central America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Intermediates Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment Of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Pharmaceutical Intermediates Market– Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 Pfizer Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Sanofi

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 BASF SE

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Lianhe Chemical Technology Co., Ltd.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Dishman Carbogen Amcis Ltd

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Codexis

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Midas Pharma GmbH

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 chiracon GmbH

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Dextra Laboratories Limited

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Vertellus Holdings LLC

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms


LIST OF TABLES

Table 1. North America Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2. North America Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 4. US Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 5. US Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. US Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 13. Europe Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Europe Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 15. Europe Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 16. Germany Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 17. Germany Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 18. Germany Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 19. UK Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 20. UK Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 21. UK Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 22. France Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 23. France Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24. France Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 25. Spain Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 26. Spain Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 27. Spain Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 28. Italy Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 29. Italy Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 30. Italy Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of Europe Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 32. Rest of Europe Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 33. Rest of Europe Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 34. Asia Pacific Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 35. Asia Pacific Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 36. Asia Pacific Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 37. China Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 38. China Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 39. China Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 40. Japan Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 41. Japan Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 42. Japan Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 43. India Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 44. India Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 45. India Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 46. Australia Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 47. Australia Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 48. Australia Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 49. South Korea Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 50. South Korea Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 51. South Korea Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 52. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 53. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 54. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 55. Middle East and Africa Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 56. Middle East and Africa Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 57. Middle East and Africa Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 58. Saudi Arabia Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 59. Saudi Arabia Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 60. Saudi Arabia Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 61. UAE Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 62. UAE Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 63. UAE Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 64. South Africa Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 65. South Africa Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 66. South Africa Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 67. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 68. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 69. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 70. South and Central America Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 71. South and Central America Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 72. South and Central America Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 73. Brazil Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 74. Brazil Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 75. Brazil Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 76. Argentina Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 77. Argentina Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 78. Argentina Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 79. Rest of South and Central America Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 80. Rest of South and Central America Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 81. Rest of South and Central America Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 82. Organic Developments Done By Companies

Table 83. Inorganic Developments Done By Companies

Table 84. Glossary of Terms, Pharmaceutical Intermediates Market

LIST OF FIGURES

Figure 1. Pharmaceutical Intermediates Market Segmentation

Figure 2. Pharmaceutical Intermediates Segmentation, By Region

Figure 3. Global Pharmaceutical Intermediates Market Overview

Figure 4. GMP Held Largest Share of Type Segment in Pharmaceutical Intermediates Market

Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6. Pharmaceutical Intermediates Market, by Geography (US$ Million)

Figure 7. Global Pharmaceutical Intermediates Market– Leading Country Markets (US$ Million)

Figure 8. Global Pharmaceutical Intermediates Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. APAC: PEST Analysis

Figure 12. MEA: PEST Analysis

Figure 13. SCAM: PEST Analysis

Figure 14. Expert Opinion

Figure 15. Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints

Figure 16. Global Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2020- 2028

Figure 17. Global Pharmaceutical Intermediates Market– By Geography Forecast and Analysis – 2020- 2028

Figure 18. Market Positioning of Key Players in Global Pharmaceutical Intermediates Market

Figure 19. Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)

Figure 20. GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21. Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22. Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)

Figure 23. Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24. Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25. Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26. Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27. Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)

Figure 28. Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29. Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. North America: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 31. North America Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)

Figure 32. North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 33. US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. Europe: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 37. Europe Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)

Figure 38. Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 39. Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 42. Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 43. Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 44. Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 45. Asia Pacific: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 46. Asia Pacific Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)

Figure 47. Asia Pacific: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 48. China: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. Japan: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. India: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 51. Australia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 52. South Korea: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 53. Rest of Asia Pacific: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 54. Middle East and Africa: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 55. Middle East and Africa Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)

Figure 56. Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 57. Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 58. UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 59. South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 60. Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 61. South and Central America: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)

Figure 62. South and Central America Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)

Figure 63. South and Central America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)

Figure 64. Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 65. Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 66. Rest of South and Central America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)

Figure 67. Impact of COVID-19 Pandemic in North American Country Markets

Figure 68. Impact of COVID-19 Pandemic in European Country Markets

Figure 69. Impact of COVID-19 Pandemic on Pharmaceutical Intermediates Market in Asia Pacific Countries

Figure 70. Impact of COVID-19 Pandemic in Middle East and Africa Market

Figure 71. Impact of COVID-19 Pandemic in South and Central America Market

Figure 72. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Pharmaceutical Intermediate Market

  1. Pfizer Inc.
  2. Sanofi
  3. BASF SE
  4. Lianhe Chemical Technology Co., Ltd
  5. Dishman Carbogen Amcis Ltd
  6. Codexis
  7. Midas Pharma GmbH
  8. chiracon GmbH
  9. Dextra Laboratories Limited
  10. Vertellus Holdings LLC
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmaceutical intermediate market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global pharmaceutical intermediate market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00005559
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Download PDF Brochure


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount
  Share   Share   Share